ExpreS2ion Biotechnologies

ExpreS2ion Biotechnologies is at the forefront of biotechnology, dedicated to the development of innovative vaccines and immunotherapy products. With a focus on creating solutions for a healthier world, ExpreS2ion Biotechnologies leverages its proprietary recombinant expression system, ExpreS2 TM, to efficiently produce complex proteins essential for pioneering vaccines, immunotherapies, and diagnostics.

Located at Agern Allé 1, Horsholm, 2970, DK, ExpreS2ion Biotechnologies is committed to advancing healthcare through cutting-edge research and development. The company's work extends to novel plug-&-play capsid virus-like particle (cVLP) platforms, offering advancements in long-term efficacy, safety, stability, and cost-effectiveness. ExpreS2ion Biotechnologies has a robust pipeline of projects, including clinical-stage malaria vaccine initiatives and preclinical-stage influenza and CMV vaccines, developed in collaboration with leading research institutions.

ExpreS2ion Biotechnologies continues to drive innovation and excellence in the biotechnology field. We invite the management team of ExpreS2ion Biotechnologies to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and reach.